682
Participants
Start Date
September 13, 2018
Primary Completion Date
December 1, 2020
Study Completion Date
December 1, 2020
Brimonidine Tartrate Ophthalmic Suspension
PDP-716
Brimonidine Tartrate Ophthalmic Solution
Three Times Brimonidine Tartrate Ophthalmic Solution
SPARC Site 15, Poughkeepsie
SPARC Site 36, Rochester
SPARC Site 24, Cranberry Township
SPARC Site 40, Bowie
SPARC Site 17, Winston-Salem
SPARC Site 9, High Point
SPARC Site 30, Gastonia
SPARC Site 22, Roswell
SPARC Site 2, Morrow
SPARC Site 42, Atlanta
SPARC Site 21, Jacksonville
SPARC Site 46, Hollywood
SPARC Site 41, Pompano Beach
SPARC Site 29, Deerfield Beach
SPARC Site 11, Coral Springs
SPARC Site 35, Miami
SPARC Site 27, Miami
SPARC Site 10, Miami
SPARC Site 16, Miami
SPARC Site 19, Miami
SPARC Site 25, Miami
SPARC Site 18, Tampa
SPARC Site 34, Fort Myers
SPARC Site 32, Memphis
SPARC Site 23, Paducah
SPARC Site 8, Cleveland
SPARC Site 37, Cincinnati
SPARC Site 33, Fargo
SPARC Site 12, Chicago
SPARC Site 31, St Louis
SPARC Site 28, Kansas City
SPARC Site 48, Kansas City
SPARC Site 39, Houston
SPARC Site 20, San Antonio
SPARC Site 13, Mission
SPARC Site 7, Colorado Springs
SPARC Site 4, Chandler
SPARC Site 3, Sun City
SPARC Site 5, Prescott
SPARC Site 47, Torrance
SPARC Site 44, Glendale
SPARC Site 45, Glendale
SPARC Site 43, Mission Hills
SPARC Site 38, Burbank
SPARC Site 1, Newport Beach
SPARC Site 14, Santa Barbara
SPARC Site 26, Saint Albans
Sun Pharma Advanced Research Company Limited
INDUSTRY